TABLE 2

AIs of ¹⁸F-FCWAY BP and CMRglu Before and After PVC

Region	¹⁸F-FCWAY BP											CMRglu
		Before PVC					After PVC					Before PVC			After PVC
		Controls	Patients	P	Controls	Patients	P	Patients	P	Patients	P
Superior temporal	−3 ± 8	−8 ± 12		4 ± 9	3 ± 30		−7 ± 13		1 ± 28
Middle temporal	−5 ± 12	−7 ± 11		3 ± 8	2 ± 28		−11 ± 14		−6 ± 26
Inferior temporal	−3 ± 13	−14 ± 13	∗	2 ± 11	−12 ± 19	∗	−12 ± 13		−11 ± 22
Fusiform gyrus	3 ± 11	−17 ± 21	∗	4 ± 13	−15 ± 23	∗	−12 ± 14		−11 ± 20
Parahippocampus	4 ± 5	−21 ± 16	^‡	1 ± 8	−20 ± 16	∗	−8 ± 12	^‡	−8 ± 14	^§
Hippocampus	4 ± 7	−42 ± 26	^‡	4 ± 8	−40 ± 25	^‡	−14 ± 14	^‡	−13 ± 16	^‡
Amygdala	2 ± 15	−20 ± 20	∗	−4 ± 12	−17 ± 19	∗	−10 ± 14	^§	−9 ± 14
Frontal	3 ± 4	1 ± 7		4 ± 3	4 ± 15		−2 ± 3		0 ± 9
Parietal	1 ± 5	−2 ± 13		2 ± 4	−3 ± 14		−2 ± 4		−3 ± 5
Insula	1 ± 6	−7 ± 11	∗	−1 ± 4	−5 ± 14		−6 ± 6		−5 ± 8
Occipital	2 ± 9	−2 ± 6		2 ± 12	−2 ± 11		−2 ± 3		−2 ± 11

↵* Uncorrected P < 0.05, controls vs. patients, unpaired t test.
↵^‡ P < 0.05 after correction for multiple comparisons, controls vs. patients, unpaired t test.
↵^‡ P < 0.05 after correction for multiple region comparisons, ¹⁸F-FCWAY vs. ¹⁸F-FDG in patient group, paired t test.
↵^§ Uncorrected P < 0.05, ¹⁸F-FCWAY vs. ¹⁸F-FDG in patient group, paired t test.